# Proteome Analysis of Nasolacrimal Duct Lavage Fluid in Patients with Primary Acquired Nasolacrimal Duct Obstruction

**Authors:** Heejeong You, Wonseok Bang, Byeongsoo Kang, Seunghoon Back, Junyoung Park, Minjung Ju, Jong-Moon Park, Helen Lew

PMC · DOI: 10.3390/ijms27062616 · International Journal of Molecular Sciences · 2026-03-12

## TL;DR

This study identifies distinct protein profiles in the nasolacrimal duct of patients with tear drainage blockage, revealing biochemical differences between two obstruction types.

## Contribution

The study provides the first detailed proteomic analysis of nasolacrimal duct lavage fluid and identifies subtype-specific molecular features in PANDO.

## Key findings

- NLD lavage fluid contains 1345 unique proteins, distinct from tear fluid's 767 proteins.
- Membranous obstruction is linked to keratinization-related proteins like KRT1 and KLK13.
- Mucinous obstruction shows upregulation of lipid and sulfur metabolism proteins like ALOX15B and GSTM4.

## Abstract

Primary acquired nasolacrimal duct obstruction (PANDO) is a common cause of epiphora in adults, yet the biochemical environment within the nasolacrimal duct (NLD) remains poorly understood. This study aimed to characterize the proteomic composition of NLD lavage fluid and identify subtype-specific molecular features distinguishing membranous and mucinous obstruction. Paired tear and NLD lavage fluid (NLD-LF) samples were collected from patients undergoing dacryoendoscopic recanalization, and proteomic profiling was performed using LC–MS/MS. A total of 1345 proteins were identified in NLD-LF and 767 in tear fluid, revealing a distinct NLD-specific proteome. Although the membranous and mucinous subtypes shared broadly similar protein compositions, differentially expressed proteins highlighted divergent biochemical pathways. The membranous subtype showed enrichment of keratinization-related processes involving KRT1, KRT9, and KLK13, suggesting epithelial remodeling and cornification. In contrast, the mucinous subtype exhibited upregulation of proteins involved in lipid metabolism, carboxylic acid biosynthesis, and sulfur compound metabolism, including ALOX15B, LCAT, and GSTM4, indicating metabolic conditions that promote mucin–lipid interactions, glycan sulfation, and redox-dependent mucin cross-linking. These findings provide new insights into the protein composition of NLD lavage fluid and suggest molecular differences between the membranous and mucinous obstruction subtypes.

## Linked entities

- **Genes:** KRT1 (keratin 1) [NCBI Gene 3848], KRT9 (keratin 9) [NCBI Gene 3857], KLK13 (kallikrein related peptidase 13) [NCBI Gene 26085], ALOX15B (arachidonate 15-lipoxygenase type B) [NCBI Gene 247], LCAT (lecithin-cholesterol acyltransferase) [NCBI Gene 3931], GSTM4 (glutathione S-transferase mu 4) [NCBI Gene 2948]

## Full-text entities

- **Genes:** ALOX15B (arachidonate 15-lipoxygenase type B) [NCBI Gene 247] {aka 15-LOX-2}, GSTM4 (glutathione S-transferase mu 4) [NCBI Gene 2948] {aka GSTM4-4, GTM4}, mucin [NCBI Gene 100508689], KRT9 (keratin 9) [NCBI Gene 3857] {aka CK-9, EPPK, K9}, LCAT (lecithin-cholesterol acyltransferase) [NCBI Gene 3931], KRT1 (keratin 1) [NCBI Gene 3848] {aka AEI2, CK1, EHK, EHK1, EPPK, K1}, KLK13 (kallikrein related peptidase 13) [NCBI Gene 26085] {aka KLK-L4, KLKL4}
- **Diseases:** mucinous (MESH:D002288), epiphora (MESH:D007766), Nasolacrimal Duct (MESH:D007767), membranous and mucinous obstruction (MESH:D015433)
- **Chemicals:** carboxylic acid (MESH:D002264), sulfur compound (MESH:D013457), glycan (MESH:D011134), lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13026466/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13026466/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC13026466/full.md

---
Source: https://tomesphere.com/paper/PMC13026466